Workflow
Aurora 发电站
icon
Search documents
Oklo or NANO Nuclear: Which Microreactor Stock Has the Edge?
ZACKS· 2025-06-26 13:51
Core Insights - The global clean energy sector is evolving, with nuclear energy stocks like Oklo Inc. (OKLO) and NANO Nuclear Energy Inc. (NNE) gaining attention due to rising government support and investment in small modular and advanced nuclear technologies [1][2] Group 1: Company Achievements - Oklo's subsidiary, Atomic Alchemy, began site characterization work for a commercial radioisotope production facility in Idaho in June 2025 [3] - Oklo received a Notice of Intent to Award for deploying its Aurora powerhouse at Alaska's Eielson Air Force Base, which would allow it to design, build, and operate the plant [4] - The U.S. Nuclear Regulatory Commission started reviewing Oklo's Licensed Operator Topical Report, indicating progress towards obtaining a license for its Aurora powerhouses [5] - NANO Nuclear signed a Memorandum of Understanding with the Namibia Industrial Development Agency to explore building a domestic nuclear fuel supply chain in Namibia [8] - NANO Nuclear filed six new utility patent applications for its ZEUS microreactor, showcasing its commitment to innovation in compact nuclear technologies [9] Group 2: Financial Stability - Oklo ended Q1 2025 with $201 million in cash and cash equivalents, indicating a solid financial footing to support its Aurora powerhouse development [6] - NANO Nuclear ended the fiscal second quarter of 2025 with $119 million in cash and cash equivalents, also showing a strong liquidity position [10][11] Group 3: Challenges - Oklo is in the pre-revenue stage, with its first Aurora powerhouse not expected to be operational until 2027, leading to limited income opportunities in the short term [7] - NANO Nuclear is also in the pre-revenue stage, focusing on R&D for its microreactors, which presents limited income opportunities and long regulatory timelines [12] Group 4: Earnings Estimates - The Zacks Consensus Estimate for Oklo's 2025 EPS is a loss of 46 cents per share, an improvement from a loss of 74 cents per share the previous year [13] - The Zacks Consensus Estimate for NNE's fiscal 2025 EPS is a loss of $1.05 per share, a deterioration from a loss of 39 cents per share the previous year [14] Group 5: Stock Performance and Valuation - Oklo shares increased by 549.2% year over year, significantly outperforming NNE's 119.9% stock price gain [10][18] - Oklo's trailing 12-month Price/Book (P/B TTM) ratio is 28.72X, compared to NNE's 10.02X, indicating that NNE may offer a more attractive valuation [19] Group 6: Conclusion - Oklo has a stronger cash position and recent regulatory progress, while NANO Nuclear is at an earlier stage with a smaller capital base [22] - Oklo shows stronger stock momentum and improving EPS trends, while NNE appeals to value-oriented investors [23]